Quanterix Corporation Common Stock (QTRX) is a publicly traded Healthcare sector company. As of May 21, 2026, QTRX trades at $2.53 with a market cap of $118.71M and a P/E ratio of -1.08. QTRX moved +0.00% today. Year to date, QTRX is -60.81%; over the trailing twelve months it is -49.50%. Its 52-week range spans $2.40 to $15.67. Analyst consensus is neutral with an average price target of $4.00. Rallies surfaces QTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own QTRX include Exoduspoint Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Quanterix Corporation Common Stock.
| Metric | Value |
|---|---|
| Price | $2.53 |
| Market Cap | $118.71M |
| P/E Ratio | -1.08 |
| EPS | $-2.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.67 |
| 52-Week Low | $2.40 |
| Volume | 1 |
| Avg Volume | 0 |
| Revenue (TTM) | $144.98M |
| Net Income | $-104.19M |
| Gross Margin | 44.22% |
2 analysts cover QTRX: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $4.00.